Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Imeik Technology Development Co
AddedFeb 20, 2024
UpdatedJun 28, 2026
Imeik Technology Development Co

Imeik Technology Development Co

Beijing-based Imeik Technology develops and distributes biomedical products and medical devices.

HQ
Beijing, Beijing, CN
Founded
2004
Overview
Compare
Employees

Imeik Technology Development Co, based in Beijing, focuses on developing and distributing biomedical products and medical devices. Their offerings include sodium hyaluronate, collagens, and polylactic acids, catering to the healthcare and medical sectors.

Imeik Technology has made significant strides in the biomedical field, contributing to advancements in medical treatments and patient care. Their products are widely used in various medical applications, enhancing the quality of healthcare services.

Imeik Technology Development Co - Similar Companies

Bimi International Medical logo

Bimi International Medical

usbimi.com

ImCare Biotech logo

ImCare Biotech

Haohai Biological Technology logo

Haohai Biological Technology

Imbed Biosciences logo

Imbed Biosciences

imbedbio.com

Beijing Whale Technology logo

Beijing Whale Technology

BiomedInnovations logo

BiomedInnovations

Biomimedica logo

Biomimedica

biomimedica.com

Integrated Micro-Chromatography Systems logo

Integrated Micro-Chromatography Systems

imcstips.com

BioRay Pharmaceuticals logo

BioRay Pharmaceuticals

Miach Orthopaedics logo

Miach Orthopaedics

miachortho.com

Ikotech logo

Ikotech

Blaire Biomedical logo

Blaire Biomedical

International Biomedical Devices logo

International Biomedical Devices

aperturectc.com

Aesthetics Biomedical logo

Aesthetics Biomedical

Cytophil logo

Cytophil

cytophil.com

Imeik Technology Development Co - Quick Facts

Who are Imeik Technology Development Co's competitors?

Companies similar to Imeik Technology Development Co include Bimi International Medical, ImCare Biotech, Haohai Biological Technology and Imbed Biosciences.

When was Imeik Technology Development Co founded?

Imeik Technology Development Co was founded in 2004.

Where is Imeik Technology Development Co's headquarters located?

Imeik Technology Development Co's headquarters is located in Beijing, Beijing, CN.

How many employees does Imeik Technology Development Co have?

Imeik Technology Development Co has 713 employees as of Feb 12, 2024.

Imeik Technology Development Co - Classification

Industry
  • Hardware
Ownership
  • Private
Revenue
  • Recurring
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Biomedical Products
  • Medical Devices
Tags
  • Biotech
  • Distribution
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 325000Chemical Manufacturing
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 2830Drugs
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8731Commercial Physical and Biological Research